Europe

Novel Antimicrobial Peptides against Cutibacterium Acnes designed by Deep Learning via Nature

The increasing prevalence of antibiotic resistance in Cutibacterium acnes (C. acnes) requires the search for alternative therapeutic strategies. Antimicrobial peptides (AMPs) offer a promising avenue for the development of new treatments targeting C. acnes.

In this study, to design peptides with the specific inhibitory activity against C. acnes, we employed a deep learning pipeline with generators and classifiers, using transfer learning and pretrained protein embeddings, trained on publicly available data. To enhance the training data specific to C. acnes inhibition, we constructed a phylogenetic tree.

A panel of 42 novel generated linear peptides was then synthesized and experimentally evaluated for their antimicrobial selectivity and activity. Five of them demonstrated their high potency and selectivity against C. acnes with MIC of 2–4 µg/mL. Our findings highlight the potential of these designed peptides as promising candidates for anti-acne therapeutics and demonstrate the power of computational approaches for the rational design of targeted antimicrobial peptides.

Read more

Recent Posts

We Are Testing at HPCI India 2025

HPCI India has been an Industry-Connect Partner for 10+ years and has established itself as…

ADAT, experts in clinical data certification and analysis since 25 years

Welcome to ADAT Europe At ADAT, we are dedicated to providing state-of-the-art solutions in data…

We Are Testing at in-cosmetics Asia 2024 – The best place to talk about testing

in-cosmetics Asia is the leading personal care and cosmetic ingredient event in Asia Pacific, bringing…